Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass

The Annals of Thoracic Surgery

Volumn 55, Issue 4, 1993, Pages 917-922

  Gu, Y J ^a   van Oeveren, Willem ^a   Akkerman, Cornelia ^a   Boonstra, Piet W ^a   Huyzen, Rob J ^a   Wildevuur, Charles R H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL;

AGED; CARDIOPULMONARY BYPASS; COMPLEMENT 3A; CORONARY ARTERY BYPASS; HEMOGLOBIN A; HEPARIN; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; MIDDLE AGE; PANCREATIC ELASTASE; SUPPORT, NON-U.S. GOV'T;

EID: 0027156091     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(93)90117-Z     Document Type: Article

References (30)

1. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins
2. Complement and the damaging effects of cardiopulmonary bypass
3. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation
4. Blood compatibility of cardiopulmonary bypass circuits
5. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution
6. Complement activation and neutropenia occurring during cardiopulmonary bypass
7. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit
8. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass [Editorial]
9. Heparin bonding on colloidal graphite surfaces
10. Heparinized polyurethanes: in vitro and in vivo studies
11. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization
12. Heparin coating of extracorporeal circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass
13. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control protie bound C3b
14. Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase
15. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig
16. A heparin coated circuit reduces complement activation and the release of leukocyte inflammatory mediators during extracorporeal circulation in rabbit
17. Complement and complement fixation
18. Tumor necrosis factor (TNF)
19. Release of tumor necrosis factor by human polymorphonuclear leukocytes
20. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass
21. Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation
22. Membrane oxygenator prevents lung reperfusion injury in canine cardiopulmonary bypass
23. Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement
24. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state
25. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass
26. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass
27. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass
28. Reduced complement activation with heparincoated oxygenator and tubings in coronary bypass operations
29. Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin
30. Demonstration of specific C5a receptors on intact human polymorphonuclear leukocytes